Articles

• FDA Approves First Therapy for the Treatment of Adult Patients with a Rare Blood Clotting Disorder
• FDA Issues Letter to Healthcare Providers Alerting Them to a Risk for Breast Implant Associated–Anaplastic Large-Cell Lymphoma

Read More ›

• FDA Resumes Operations After Government Shutdown Ends
• FDA Approves New Drug Indication for Use in Hepatocellular Carcinoma
• FDA Approves Pembrolizumab for Merkel-Cell Carcinoma

Read More ›

Now in its fourth week, the longest shutdown in the history of the federal government is having an impact on patient care, as the US Food and Drug Administration (FDA) has put drug reviews and approvals for new drugs and devices, as well as the issuance of new guidance documents, on indefinite hold. Read More ›

The Oncology Nurse-APN/PA spoke with Tonya Edwards, MS, RN, MSN, FNP-C, who discusses how The University of Texas M.D. Anderson Cancer Center focuses on counseling and supporting patients with cancer who receive opioids for pain relief. Read More ›

The November issue of The Oncology Nurse-APN/PA (TON) is packed with important news and insights for today’s oncology nurse. Read More ›

In the CHAMPION-1 study, patients with relapsed or refractory multiple myeloma and 1 to 3 previous regimens who received once-weekly carfilzomib had a 77% overall response rate and a median PFS of 12.6 months. Read More ›

Omega-3 fatty acids significantly reduced aromatase inhibitor (AI)-induced joint pain in obese women with breast cancer, according to a new retrospective analysis of the SWOG S0927 study, a 24-week, randomized, controlled clinical trial that compared omega-3 fatty acids and placebo in patients with AI-related arthralgia. Read More ›

“Survivors of different ages, different lifestyles, and different cultures need different types of resources, and the number of resources that are needed is huge,” Dr Messner added. Read More ›

According to Ann M. Berger, PhD, MSN, APRN, AOCNS, FAAN, Professor and Dorothy Hodges Olson Endowed Chair in Nursing, College of Nursing, University of Nebraska Medical Center, Omaha, there is an urgent need for further research in this area to alleviate these symptoms and enhance quality of life among survivors of all types of cancer. Read More ›

Recent surveys have revealed that up to 25% of patients with cancer take some form cannabis, but oncologists and other medical providers are often unaware that their patients are using medical or recreational cannabis. Read More ›